Summary Based on data from the Nordic cancer registries, time-related trends in incidence of Kaposi's sarcoma (KS) were analysed in four ethnically similar populations before the AIDS epidemic. Data were available for different time periods in Denmark (1970-79), Sweden (1958-79), Finland (1953 and Norway (1953-79). KS was more common among men than among women aged 60 years or more, whereas no differences were observed for younger persons. The incidence of KS differed significantly between the four countries (P=0.0001); Sweden having the highest and Denmark the lowest rates. Similarly, regional differences in incidence were observed within Sweden, rates being higher in the northern than in the southern areas (Ptrend = 0.002). Overall, in Nordic men the world standardised incidence rose from 0.5/1 000 000 person -years in the period 1953-57 to 1.8/1 000 000 person-years in 1978-79; in Nordic women, the corresponding rates were 0.2/1 000 000 person-years and 0.8/1 000 000 person-years respectively. The rate of increase was similar in Sweden, Finland and Norway (P=0.14), whereas the short period of observation in Denmark precluded precise assessment of time-related incidence trends. These observations cannot be explained by registrational procedures or known risk factors for KS, and argue that environmental factors play an important role in the development of the disease.
One of the hallmarks of the onset of the AIDS epidemic in the early 1980s was the sudden increase in incidence of Kaposi's sarcoma (KS) . This increase in the occurrence of a previously exceedingly rare condition naturally prompted a renewed interest in its epidemiology, including assessment of the incidence before the AIDS epidemic. From such studies, it became evident that the incidence of KS differed considerably between European countries. Thus, even taking the use of different standard populations into account, the rates reported for Italy, 10.5/1 000 000 person-years and 2.7/1 000 000 person-years in men and women respectively (Geddes et al., 1994) , by far exceeded the rates reported for England and Wales, being 0.14/1 000 000 person-years in both men and women (Grulich et al., 1992) .
Because of the rareness of KS, the quality of registry data is critically dependent on the reporting infrastructure. This, and the fact that only a few countries have longer traditions for cancer registrations, are presumably the main reasons why only a few reports have presented data for more than one decade before the AIDS epidemic. Accordingly, only a little is known about the time-related incidence trends of KS. Interestingly, however, at least one study suggested that the incidence of KS increased before the AIDS epidemic (Dictor and Attewell, 1988) .
The objective of the present study was to provide further information about the epidemiology of KS in four ethnically similar Nordic populations in the pre-AIDS era. To this purpose, we took advantage of the long history and high quality of cancer registration in the Nordic countries to investigate time-related trends in classical KS and to provide incidence rates from a large north European area, populated by 22 million people in 1980.
Materials and methods
The structures of the Nordic cancer registries have been described in detail elsewhere (Hakulinen et al., 1986) . In brief, the registries record all cases of cancers in the national populations using almost identical procedures and classifications. The ascertainment rate of the registries is high, ensuring close to 100% completeness (Hakulinen et al., 1986) . To avoid potential misclassification between classical KS and AIDS-KS, the present study was restricted to the period before 1980.
In Denmark, KS has been registered as a separate entity only since 1978. Cases for the period 1970-77 were sought in the Danish Cancer Registry under codes for potentially relevant skin cancers and sarcomas according to a modified version of the seventh revision of the International Classification of Diseases (ICD-7). Cases diagnosed in 1978 and 1979 were identified by searches under codes for KS and for morphologically closely related tumours, including angiosarcomas, according to the International Classification of Diseases, Oncology (ICD-O). In addition to these searches, cases were manually sought in all Danish pathology departments, applying a similar search strategy. Finally, in questionable cases the search for KS included examination of histological slides and/or scrutiny of the original pathology reports.
In the Swedish Cancer Registry, KS has been registered separately since 1958. As part of a previous study (Dictor and Attewell, 1988) , all notifications of KS, reported either originally as KS or erroneously as angiosarcomas, were identified and validated.
In Norway, KS has been registered since 1953. As part of a previous report (Harvei et al., 1990) Statistical methods The material was divided into five year intervals (1953-57, 1958-62, 1973-77, 1978-1979) and five year age groups. Age-and sex-specific incidence rates were calculated for each country and for the four countries combined, using population data from the respective national bureaux of statistics. Based on these rates, age-adjusted incidence rates were calculated by means of direct standardisation, using the world standard population as reference (Breslow and Day, 1980) .
Multivariate modelling of the incidence rates with respect to sex, age, calendar time and country was performed. For this purpose, the patient material was divided into two groups according to the age of diagnosis, i.e. patients younger than 60 years and those 60 years or older. The modelling was performed by means of Poisson regression analysis using the backward elimination procedure (Kleinbaum et al., 1988) .
Finally, in order to evaluate local differences in the incidence of KS, Swedish patients were divided into six groups corresponding to the six regional cancer registries. Trends in incidence from south to north were analysed by means of Poisson regression analysis (Kleinbaum et al., 1988) , attributing the respective latitudes of the centres of population to each of the six regions (Table III) .
Results
A total of 723 cases of KS, 481 in men and 242 in women, were identified. The distribution of the cases with regard to geography, sex and age is given in Tables I and II. In both sexes the incidence of KS increased with age (Table II) , and overall, the incidence of KS was higher among men than among women (Figure 1 ). The male excess was primarily restricted to the age group > 60 years (P<0.0001), whereas the male-female rate ratio did not differ significantly from unity among patients younger than 60 years (P=0.26). During the study period, the incidence of KS differed significantly between the four countries ( Figure 1) . Although not constantly, the highest incidence rates in general were observed in Sweden, followed by Norway, Finland and Denmark. In the period 1973-77, for example, the world standardised incidence of KS among men was 0.2/1 000 000 person-years in Denmark, 1.0/1 000 000 person-years in Finland, 1.9/1 000 000 person-years in Norway, and 2.6/ 1 000 000 person-years in Sweden. Among women the corresponding rates were 0.1/1 000 000 person -years in Denmark, 0.8/1 000000 person-years in Finland, 0.9/ 1000000 person-years in Norway and 0.8/1 000000 person-years in Sweden. These differences in incidence were evident throughout most of the study period and varied only insignificantly between Sweden, Norway and Finland (P = 0.14). Contrary to this, the time-related variation in incidence differed significantly between Denmark and the other countries (P=0.03).
Apart from the intra-Nordic differences in incidence, regional differences in the incidence of KS were also observed within Sweden, the incidence being significantly higher in the northern than in the southern parts of Sweden (test for linearity: X2=6.96, 3 d.f., P=0.07; test for linear trend: X2=9.62, 1 d.f., P=0.0019) (Table III) .
Overall, the incidence of KS in the Nordic area as a whole increased during the study period. Thus, between 1958-62 and 1978-79 the world standardised incidence of KS in the Nordic area increased from 1.1/1 000 000 person-years in men and 0.2/1 000 000 person-years in women (three countries contributing) to 1.8/1 000 000 person-years in men and 0.7/1 000 000 person-years in women (four countries contributing) (Figure 1 ). The increase was observed in both the young (<60 years) and the old (>3 60 years) age group (Table II) . The rate of increase was similar in the three countries with the longest periods of observation, 2.80a aCrude incidence rates per 1 000 000 person years. , 1994) . Rather, a number of observations indicate that the incidence variation is real. This includes the consistency of the differences in KS incidence between the three countries contributing the majority of cases, the very low incidence of KS in Denmark compared with the other countries, along with the geographical differences in Sweden. Additional evidence of considerable variation in KS incidence comes from other studies of KS in the period before the AIDS epidemic. Apart from the previously mentioned studies from England and Wales (Grulich et al., 1992) and Italy (Geddes et al., 1994) , age-adjusted rates have been reported from the US for the period 1973-79 (2.9/ 1 000 000 person-years in men and 0.7/1 000 000 personyears in women) (Biggar et al., 1984) and from Australia for the period 1972-82 (0.65/1 000 000 person-years in men and 0.29/1 000 000 person-years in women) (Kaldor et al., 1994) . Moreover, extremes such as complete absence of KS in the Swiss canton of Vaud in the period (Levi et al., 1993) , and crude rates of 16/1 000 000 person-years in men and women in Sardinia in the period 1977 -82 (Cerimele et al., 1984 have also been published. While these differences may be more difficult to interpret, it seems unlikely that they should result from differences in registrational procedures or standardisation alone (Geddes et al., 1994) .
Unlike the above-mentioned studies, the long tradition of cancer registration in the Nordic countries allowed for evaluation of time-related incidence trends. Accordingly, it was demonstrated that the incidence of KS increased in the Nordic countries before the AIDS epidemic. This increase cannot easily be explained. The incidence of KS increased with age and, given the general improvements in health care for elderly persons that have taken place during the study period, part of the increase among those aged 60 years or more may be accounted for by diagnostic improvements. Even though only two cases of KS were found among 5692 Scandinavian renal transplant recipients in a recent study (Birkeland et al., 1995) , iatrogenic immune suppression, such as in organ transplant recipients, remains a well-established risk factor for KS (Kinlen, 1982; Penn, 1983; Quibini et al., 1988) . Similarly, systemic corticosteroid treatment has been suggested to confer an increased risk of KS in non-transplant recipients (Klepp et al., 1978 (Laor and Schwartz, 1979; Friedman-Birnbaum et al., 1990; Kaldor et al., 1994; Grulich et al., 1992; DiGiovanna and Safai, 1981) . Although an excess of immigrants has been observed among Danish patients with non-AIDS-related KS in the period (Hjalgrim et al., 1996) , less than 5% of the Swedish and Norwegian cases of KS were diagnosed in persons of foreign descents (Dictor and Attewell, 1988; Harvei et al., 1990) . Thus, differences in immigration patterns within the Nordic area can explain neither the differences in incidence nor the observed increase.
Support for an infectious aetiology in KS pathogenesis is accumulating (Beral et al., 1990 . DNA sequences from a Herpesvirus have recently been detected in both AIDSrelated and classical KS lesions (Su et al., 1995; Chang et al., 1994) and culturing of the virus has been reported (Renne et al., 1996) . If involved in the aetiology of KS, differences in the prevalence of the virus with respect to time and place or in cofactors determining disease progression offer a plausible explanation for the observed geographic variation and the observed increase in KS incidence. The virus has been isolated in plasma (Whitby et al., 1995) and, in theory, it should be able to survive Cohn fractionation in the process of gamma globulin production. Although purely speculative, we note that during the study period, the consumption of gamma globulin increased considerably in the Nordic countries and that sources of gamma globulin differed between the countries. Thus, while gamma globulin in Denmark was based on plasma from Danish donors, gamma globulin used in the other countries was to a large extent either imported or produced from imported plasma, including large imports from KS-endemic areas, such as Italy.
In conclusion, the incidence of registered cases of classical KS increased in the Nordic area before the AIDS epidemic. In the early years of the study period, significantly improved diagnostic tools and hardly measurable changes in the classification of this rare tumour may have played a role. What should be emphasised, however, is the remarkable geographical variation in KS incidence figures that exist between ethnically quite similar populations, such as the Nordic countries.
